Key facts
- This page summarizes MORGAN STANLEY's Form 4 filing for ALIMERA SCIENCES INC.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Feb 2022, 20:11.
MORGAN STANLEY - 08 Feb 2022 Form 4 Insider Report for ALIMERA SCIENCES INC
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 08 Feb 2022
- Net transaction value
- -$1,137,500
- SEC form
- 4
- Accepted by SEC
- 10 Feb 2022, 20:11:11 UTC
- Prior SEC filing
- 10 Feb 2022
- Next SEC filing
- 27 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Joseph Maehr, Authorized Signatory
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
MORGAN STANLEY filed Form 4 for ALIMERA SCIENCES INC on 10 Feb 2022.
Change
- Previous filing in this sequence was filed on 10 Feb 2022.
- Current net transaction value: -$1,137,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALIM
transaction
Common Stock
Sale
- Transaction value
- $1,137,500
- Shares
- -250,000
- Change %
- -31%
- Price
- $4.55
- Shares after
- 557,551
- Date
- 08 Feb 2022
- Ownership
- By Subsidiary
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
MORGAN STANLEY is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.